ScottChadderdonMD
Cardiology • Portland, ORAdult Congenital Heart Disease, Echocardiography, Non-Invasive Cardiology
Assistant Professor, Medicine, Oregon Health and Science University School of Medicine
Dr. Chadderdon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-8750
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Cardiovascular Disease, 2006 - 2009- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2002 - 2005
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2002
Certifications & Licensure
OR State Medical License 2004 - 2025
WA State Medical License 2005 - 2012- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Physical Activity and Obesity Start of enrollment: 2014 Feb 01
- 2019-06 TRISCEND Study Start of enrollment: 2020 May 06
Publications & Presentations
PubMed
- 52 citationsProinflammatory Endothelial Activation Detected by Molecular Imaging in Obese Nonhuman Primates Coincides With Onset of Insulin Resistance and Progressively Increases ...Scott M. Chadderdon, J. Todd Belcik, Lindsay Bader, Melissa A. Kirigiti, Dawn M. Peters
Circulation. 2014-01-28 - 34 citationsTricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.Rebecca T Hahn, Matthew K Lawlor, Charles J Davidson, Vinay Badhwar, Anna Sannino
Journal of the American College of Cardiology. 2023-10-24 - 67 citationsTransfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results.Susheel Kodali, Rebecca T Hahn, Isaac George, Charles J Davidson, Akhil Narang
JACC. Cardiovascular Interventions. 2022-03-14
Press Mentions
TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TROctober 29th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
